Minister orders crackdown on firms increasing medicine prices

Published April 3, 2019
Minister for National Health Services (NHS) Aamer Mehmood Kiani has ordered a countrywide crackdown on pharmaceutical companies for increasing the prices of various medicines. — File/INP
Minister for National Health Services (NHS) Aamer Mehmood Kiani has ordered a countrywide crackdown on pharmaceutical companies for increasing the prices of various medicines. — File/INP

ISLAMABAD: Minister for National Health Services (NHS) Aamer Mehmood Kiani has ordered a countrywide crackdown on pharmaceutical companies for increasing the prices of various medicines.

“Though the Drug Regulatory Authority of Pakistan (Drap) deals with the matter, being [a] government [representative] I consider myself responsible to provide relief to [the] masses and answerable to them. I am personally looking into the matter and would not tolerate illegal and unauthorised increase in the prices of medicines,” the minister said, whilst talking to Dawn.

“Some of the pharmaceutical companies have been allowed to increase the prices but it is learnt that some others have increased it by themselves. I will not spare them, as patients suffer because of it. Moreover we have decided to introduce an online facility through which people would be able to verify the prices of medicines.”

The government has been facing criticism over the increase in the prices of medicines.

Read:Medicine prices raised by up to 15pc

According to a letter of the NHS ministry, written to all provincial offices of Drap, some complaints have been received that unscrupulous elements in the pharmaceutical industry have increased the prices of their drugs over and above the approved maximum retail prices by the federal government.

The letter states that in the recent past, the maximum retail prices of 889 drugs were notified after approval by the federal government. In addition, a nine per cent increase over the notified prices was allowed for medicines.

Drap officers have been advised to monitor the maximum retail price in the market and ensure that those of drugs are not higher than the notified prices.

Moreover, stock manufactured or imported prior to the issuance of the statutory regulatory order [10th Jan 2019] must be sold at the previous maximum regulatory price. Provincial offices have been directed that in case of non-compliance, legal action may be taken against violators under the Drugs Act, 1976, and the Drap Act, 2012.

NHS Secretary Zahid Saeed told Dawn that though criticism had surfaced on social media against the inc­re­ase in prices of medicines, in most of the cases the cost had been increased by Drap because of ‘hardship’.

Published in Dawn, April 3rd, 2019

Opinion

Editorial

Sustainable path?
Updated 13 Jun, 2026

Sustainable path?

The FY27 budget is the first clear signal that the government is ready to transition from stabilisation to growth.
Prioritising education
13 Jun, 2026

Prioritising education

THOUGH the improvement in the country’s literacy rate may be slight, as highlighted by the Economic Survey, it ...
Poverty’s rise
13 Jun, 2026

Poverty’s rise

AS attention turns to the government’s plans for the coming fiscal year, one set of figures deserves particular...
A difficult story
Updated 12 Jun, 2026

A difficult story

Unless productivity becomes the dominant target of economic policy, Pakistan will continue to oscillate between crises and fragile recovery.
Rough waters
12 Jun, 2026

Rough waters

AMONGST the key potential triggers for fresh conflict in South Asia is water. The Indian state is behaving in an...
Politicised football
12 Jun, 2026

Politicised football

ALMOST three-and-half years since Lionel Messi led Argentina to FIFA World Cup glory, the latest edition of...